cytarabine and fi-700

cytarabine has been researched along with fi-700 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akinaga, S; Arai, H; Ishii, K; Kiyoi, H; Kosugi, H; Naoe, T; Ozeki, K; Shimizu, M; Shiotsu, Y; Umehara, H; Yamaji, S	1

Other Studies

1 other study(ies) available for cytarabine and fi-700

Article	Year
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Aug-01, Volume: 13, Issue:15 Pt 1 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blotting, Western; Cell Proliferation; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Leukemia; Mice; Mice, Inbred C3H; Mice, SCID; Mutation; Pyridines; Pyrimidines; Signal Transduction; STAT5 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2007

Article

Year

A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Aug-01, Volume: 13, Issue:15 Pt 1

Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blotting, Western; Cell Proliferation; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Leukemia; Mice; Mice, Inbred C3H; Mice, SCID; Mutation; Pyridines; Pyrimidines; Signal Transduction; STAT5 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2007